刘雨, 牛淑利, 李梦月, 李校天. 姜黄素治疗非酒精性脂肪性肝病的研究进展[J]. 实用临床医药杂志, 2021, 25(5): 118-124. DOI: 10.7619/jcmp.20200328
引用本文: 刘雨, 牛淑利, 李梦月, 李校天. 姜黄素治疗非酒精性脂肪性肝病的研究进展[J]. 实用临床医药杂志, 2021, 25(5): 118-124. DOI: 10.7619/jcmp.20200328
LIU Yu, NIU Shuli, LI Mengyue, LI Xiaotian. Research progress of curcumin in the treatmentof non-alcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 118-124. DOI: 10.7619/jcmp.20200328
Citation: LIU Yu, NIU Shuli, LI Mengyue, LI Xiaotian. Research progress of curcumin in the treatmentof non-alcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 118-124. DOI: 10.7619/jcmp.20200328

姜黄素治疗非酒精性脂肪性肝病的研究进展

Research progress of curcumin in the treatmentof non-alcoholic fatty liver disease

  • 摘要: 非酒精性脂肪性肝病(NAFLD)是慢性肝损伤的原因之一,发病机制复杂。胰岛素抵抗、氧化应激、肠-肝轴和线粒体功能障碍等共同导致NAFLD的发生、发展。姜黄素是一种天然多酚类物质,是治疗NAFLD的潜在药物,并已广泛开展了实验研究。本研究对NAFLD的发病机制及姜黄素对NAFLD的治疗作用进行综述。

     

    Abstract: Non-alcoholic fatty liver disease (NAFLD) is one of causes of chronic liver injury, and the pathogenesis is complex. Insulin resistance, oxidative stress, intestinal-hepatic axis and mitochondrial dysfunction lead to the occurrence and development of NAFLD. Curcumin, a natural polyphenol, is a potential drug for the treatment of NAFLD, and has been widely studied in experimental researches. This study reviewed pathogenesis of NAFLD and the therapeutic effect of curcumin on NAFLD.

     

/

返回文章
返回